Department of Gastroenterology, Hepatology and Gastrointestinal Oncology, Bogenhausen Academic Teaching Hospital, Technical University of Munich, Munich, Germany.
Division of Gastroenterology and Hepatology, Klinikum Neuperlach, Munich, Germany.
Surg Endosc. 2021 Jul;35(7):3339-3353. doi: 10.1007/s00464-020-07772-5. Epub 2020 Jul 9.
Endoscopic full-thickness resection (eFTR) using the full-thickness resection device (FTRD®) is a novel minimally invasive procedure that allows the resection of various lesions in the gastrointestinal tract including the colorectum. Real-world data outside of published studies are limited. The aim of this study was a detailed analysis of the outcomes of colonoscopic eFTR in different hospitals from different care levels in correlation with the number of endoscopists performing eFTR.
In this case series, the data of all patients who underwent eFTR between November 2014 and June 2019 (performed by a total of 22 endoscopists) in 7 hospitals were analyzed retrospectively regarding rates of technical success, R0 resection, and procedure-related complications.
Colonoscopic eFTR was performed in 229 patients (64.6% men; average age 69.3 ± 10.3 years) mainly on the basis of the following indication: 69.9% difficult adenomas, 21.0% gastrointestinal adenocarcinomas, and 7.9% subepithelial tumors. The average size of the lesions was 16.3 mm. Technical success rate of eFTR was achieved in 83.8% (binominal confidence interval 78.4-88.4%). Overall, histologically complete resection (R0) was achieved in 77.2% (CI 69.8-83.6%) while histologically proven full-wall excidate was confirmed in 90.0% (CI 85.1-93.7%). Of the resectates obtained (n = 210), 190 were resected en bloc (90.5%). We did not observe a clear improvement of technical success and R0 resection rate over time by the performing endoscopists. Altogether, procedure-related complications were observed in 17.5% (mostly moderate) including 2 cases of acute gangrenous appendicitis requiring operation.
In this pooled analysis, eFTR represents a feasible, effective, and safe minimally invasive endoscopic technique.
使用全层切除装置(FTRD®)的内镜全层切除术(eFTR)是一种新型的微创技术,可切除胃肠道的各种病变,包括结直肠。发表研究之外的真实世界数据有限。本研究的目的是详细分析不同护理水平的 7 家医院的结肠镜下 eFTR 治疗结果与实施 eFTR 的内镜医生数量之间的相关性。
在本病例系列研究中,回顾性分析了 2014 年 11 月至 2019 年 6 月期间(由 22 名内镜医生完成)所有接受 eFTR 治疗的患者的数据,分析了技术成功率、R0 切除和与操作相关的并发症的发生率。
结肠镜下 eFTR 主要用于以下适应证:69.9%的困难腺瘤、21.0%的胃肠道腺癌和 7.9%的黏膜下肿瘤,在 229 例患者中进行(64.6%为男性;平均年龄 69.3±10.3 岁)。病变平均大小为 16.3mm。eFTR 的技术成功率为 83.8%(二项式置信区间 78.4-88.4%)。总体而言,组织学上完全切除(R0)的成功率为 77.2%(CI 69.8-83.6%),而组织学上证实的全壁切除率为 90.0%(CI 85.1-93.7%)。获得的切除物(n=210)中,190 个为整块切除(90.5%)。我们没有观察到内镜医生操作时间的延长会明显提高技术成功率和 R0 切除率。总的来说,操作相关并发症发生率为 17.5%(大多为中度),包括 2 例需要手术的急性坏疽性阑尾炎。
在这项汇总分析中,eFTR 是一种可行、有效且安全的微创内镜技术。